<https://alzheon.com/#/schema/person/481ed93bfa4afb102346337fa953570e>
<http://schema.org/image>
<https://alzheon.com/alzheon-reports-industry-leading-biomarker-brain-preservation-and-clinical-effects-following-12-months-of-treatment-in-phase-2-trial-of-oral-alz-801-valiltramiprosate-in-patients-with-early-alzheim/>